Status:
COMPLETED
Stanford RAD-AT Study (Research on Anxiety and Depression - Anhedonia Treatment)
Lead Sponsor:
Stanford University
Conditions:
Anxiety
Depression
Eligibility:
All Genders
18-65 years
Brief Summary
This research study is aimed at understanding behaviors and brain circuits that relate to anxiety and depression. Our goal is to learn which circuits of the brain are involved in anxiety and how these...
Detailed Description
If you are eligible and choose to participate, we'll ask you to come in for 2 separate testing visits and 8 weeks of treatment in between. In both the pre-treatment and post-treatment testing visit, ...
Eligibility Criteria
Inclusion
- Recent experiences of anxiety and/or depression
- Ages 18-65
Exclusion
- Specific psychiatric medications (case-by-case basis)
- A diagnosis of Bipolar 1 Disorder, Schizophrenia, or Obsessive Compulsive Disorder
- Any of the following medical conditions: Parkinson's disease; liver or kidney disease; history of epilepsy or seizures; history of cardiovascular disorders (specifically orthostatic hypotension)
Key Trial Info
Start Date :
August 11 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 2 2025
Estimated Enrollment :
167 Patients enrolled
Trial Details
Trial ID
NCT02220309
Start Date
August 11 2013
End Date
April 2 2025
Last Update
January 5 2026
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Gronowski Center-5150 El Camino Real
Los Altos, California, United States, 94022
2
VAPAHCS/Palo Alto MIRECC-3801 Miranda Avenue
Palo Alto, California, United States, 94304
3
Stanford University Department of Psychiatry
Stanford, California, United States, 94305